Twist Bioscience (TWST) - Stock Price & Dividends

Twist Bioscience Corporation is a leading biotech company that specializes in the design, manufacture, and sale of synthetic DNA-based products. These products are used in a wide range of applications, including therapeutics, diagnostics, chemicals, materials, food, agriculture, and academic research.

The company's product portfolio includes synthetic genes and gene fragments, which are used by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs. These products are essential for the development of new drugs, diagnostic tools, and other innovative solutions.

In addition to synthetic genes, Twist Bioscience also offers oligo pools, which are used in targeted next-generation sequencing (NGS), CRISPR gene editing, and other applications. The company's NGS tools, including library preparation kits and custom panels, are used in diagnostic tests, population genetics research, and biomarker discovery.

Twist Bioscience is also a leading provider of methylation detection kits, which are used to study cancer and rare genetic disorders. The company's fast hybridization and full RNA sequencing workflow solution enables researchers to analyze genetic data quickly and accurately.

In response to the COVID-19 pandemic, Twist Bioscience developed synthetic SARS-CoV-2 RNA reference sequences, which are used as positive controls for diagnostic tests. The company also offers synthetic controls for other respiratory viruses, including influenza, respiratory syncytial virus, and coronaviruses.

Furthermore, Twist Bioscience provides SARS-CoV-2 Research Panels, which are used to detect and study infectious diseases in a research setting. The company's precision DNA libraries are used for antibody engineering, affinity maturation, and humanization, while its antibody optimization solution enables the simultaneous optimization of multiple characteristics of a given antibody.

Headquartered in South San Francisco, California, Twist Bioscience was founded in 2013 and has established itself as a leader in the synthetic biology industry. The company's innovative products and solutions are used by researchers and scientists around the world to advance our understanding of genetics and develop new treatments for diseases.